Sage Therapeutics cuts 40% of workforce following partial FDA rejection


Sage Therapeutics is letting go of around 276 workers following some mixed news from the U.S. Food and Drug Administration.

Previous Business bankruptcies continue to climb in Mass.
Next Shaping the future of radiology with AI